Abstract
The increased use of fluoroquinolones has led to increasing resistance to these antimicrobials, with rates of resistance that vary by both organism and geographic region. Resistance to fluoroquinolones typically arises as a result of alterations in the target enzymes (DNA gyrase and topoisomerase IV) and of changes in drug entry and efflux. Mutations are selected first in the more susceptible target: DNA gyrase, in gram-negative bacteria, or topoisomerase IV, in gram-positive bacteria. Additional mutations in the next most susceptible target, as well as in genes controlling drug accumulation, augment resistance further, so that the most-resistant isolates have mutations in several genes. Resistance to…
Citation impact
917
total citations
- FWCI
- 8.66
- Percentile
- 100%
- References
- 63
Citations per year
Authors
1Topics & keywords
Topics
Keywords
- DNA gyrase
- Topoisomerase IV
- Plasmid
- Efflux
- Microbiology
- Quinolone
- Drug resistance
- Biology
UN Sustainable Development Goals
- Good health and well-being
No related works found for this paper.